Phase I trial in oncology--theory and practice.
Klin Onkol
; 25 Suppl 2: 2S98-101, 2012.
Article
em En
| MEDLINE
| ID: mdl-23581025
ABSTRACT
Phase I trials in oncology usually enrolling patients with advanced disease who have failed standard treatment options. The primary endpoint of these studies is to establish the recommended dose and/or schedule of new drugs or drug combinations for phase II trials. The guiding principle for dose escalation in phase I trials is to avoid unnecessary exposure of patients to sub-therapeutic doses of an agent. The mission of phase I clinical trials is to accelerate the development of new anticancer drugs with the purpose of improving quality of life and survival for patients with cancer.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Ensaios Clínicos Fase I como Assunto
/
Oncologia
Limite:
Humans
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article